Advancing science.
Building Partnerships.
Real-world impact.

For more than 40 years, AlphaMed has helped bring advances in research into clinical practice. We convene expertise, build strategic partnerships, and support real-world solutions that expand prevention, early detection, evidence-based care, and patient support.

Turning evidence into impact

AlphaMed connects science with strategy to advance cancer prevention, improve care, and expand access.

Evidence
Identifying proven approaches, emerging opportunities, and gaps that need attention

Partnership
Bringing the right people, expertise, and perspectives together to build shared priorities

Implementation
Supporting education, navigation, and care strategies that put evidence into practice

Impact
Helping more people benefit from prevention, screening, timely follow-up, and high-quality care

No single organization can eliminate cervical cancer or close persistent gaps in cancer care alone. Progress depends on connecting scientific advances with clinical workflows, community priorities, patient education, and sustainable approaches to implementation.

AlphaMed works across these settings to foster partnerships and advance practical solutions that strengthen prevention, screening, follow-up, and care, particularly in rural, underserved, and safety-net communities.

The strongest solutions are built where scientific evidence, clinical reality, community priorities, and sustainable implementation meet.

AlphaMed was a driving force behind the creation of the Society for Translational Oncology (STO), an independent nonprofit advancing evidence-based oncology education and implementation.

Today, STO provides practical, independent education for oncology professionals and the broader cancer community, while AlphaMed convenes cross-sector partners to develop strategies and solutions that move promising evidence into practice. Together, we help turn knowledge into better cancer care.